For example, Kalikaki et al. reported that the discordance in KRAS and EGFR gene status between primary tumors and corresponding metastases was 24% and 28% in 25 patients with NSCLC, respectively [24]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.